nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Clinical and Correlative Study of Elotuzumab, Carfilzomib, Lenalidomide, and Dexamethasone (Elo-KRd) for Lenalidomide Refractory Multiple Myeloma in First Relapse
|
Bhutani, Manisha |
|
|
23 |
7 |
p. 535-544.e1 |
artikel |
2 |
A Phase II, Open-Label Study of an Accelerated Infusion Rate of Daratumumab in Patients With Relapsed and Refractory Multiple Myeloma
|
Stakiw, Julie |
|
|
23 |
7 |
p. 484-490 |
artikel |
3 |
Autologous Stem Cell Transplant in Lymphoma Using a Noncryopreserved Platform: An Adapted Sequential Conditioning Maintaining Dose Intensity Does not Affect Transplantation Outcomes
|
Sarmiento, Mauricio |
|
|
23 |
7 |
p. 545-551 |
artikel |
4 |
Bendamustine/Rituximab Plus Cytarabine/Rituximab, With or Without Acalabrutinib, for the Initial Treatment of Transplant-Eligible Mantle Cell Lymphoma Patients: Pooled Data From Two Pilot Studies
|
Patel, Dilan A. |
|
|
23 |
7 |
p. 552-560 |
artikel |
5 |
Clinical Analysis of Pediatric T-Cell Acute Lymphoblastic Leukemia Using the MRD-Oriented Strategy System
|
Xue, Yu-juan |
|
|
23 |
7 |
p. 477-483 |
artikel |
6 |
Editorial Board
|
|
|
|
23 |
7 |
p. A1-A2 |
artikel |
7 |
Ixazomib Versus Placebo as Postinduction Maintenance Therapy in Newly Diagnosed Multiple Myeloma Patients: An Analysis by Age and Frailty Status of the TOURMALINE-MM4 Study
|
Bringhen, Sara |
|
|
23 |
7 |
p. 491-504 |
artikel |
8 |
Listening to What Matters Most: Consumer Endorsed Patient Reported Outcome Measures (PROMs) for Use in Multiple Myeloma Clinical Trials: A Descriptive Exploratory Study
|
Beer, Hayley |
|
|
23 |
7 |
p. 505-514 |
artikel |
9 |
Real-World Patient Characteristics, Treatment Patterns, and Outcomes for Patients With Stage III or IV Classic Hodgkin Lymphoma Treated With Frontline ABVD: A Retrospective Database Review in the United States
|
Winter, Allison |
|
|
23 |
7 |
p. 527-534 |
artikel |
10 |
SOHO State of the Art Updates and Next Questions |Treatment Approaches for Nodular Lymphocyte-Predominant Hodgkin Lymphoma
|
Binkley, Michael S. |
|
|
23 |
7 |
p. 471-476 |
artikel |
11 |
Table of Contents
|
|
|
|
23 |
7 |
p. A3-A4 |
artikel |
12 |
Treatment Discontinuation Patterns for Patients With Chronic Lymphocytic Leukemia in Real-World Settings: Results From a Multi-Center International Study
|
Shadman, Mazyar |
|
|
23 |
7 |
p. 515-526 |
artikel |